Skip to content

PROTALEX INC

company.status.inactive

CIK 1099215fmd_1DVK1Z3F7WTARZVFERT4T0WSD4Services · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jun 01, 2000 to Aug 31, 2018, 43 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018
Total revenues––00000000
Research and development––22433322
Operating income––(3)(4)(6)(12)(11)(9)(4)(4)
Interest expense––11100011
Interest and investment income––00000000
Income before taxes––––(6)(12)(12)(9)(5)(5)
Income tax expense–––0000000
Net income from continuing operations––––(6)(12)(12)(9)(5)(5)
Net income(7)(3)(3)(4)(6)(12)(12)(9)(5)(5)
PROTALEX INC financial statements · FinancialMD